The US FDA's new patient affairs office will not be an actual "Office" in the official sense of the word, but will remain a group working to help patients and advocates find their way around the agency.
In part because of the bureaucratic moves that would be necessary to make such a change, the agency is instead...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?